Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward M Messing

Showing results (61-70 of 199) with videos related to

Pageof 20
Sort By:
Expert Review of Anticancer Therapy|July 23, 2025
Implementation challenges of single-instillation intravesical chemotherapy following transurethral resection of bladder tumorKamil Malshy, Alexis Steinmetz, Edward M Messing
Current Opinion in Urology|August 2, 2008
Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factorsKatia Noyes, Eric A Singer, Edward M Messing
The Canadian Journal of Urology|December 3, 2008
Androgen deprivation therapy for advanced prostate cancer: why does it fail and can its effects be prolonged?Eric A Singer, Dragan J Golijanin, Edward M Messing
Clinical Genitourinary Cancer|December 1, 2024
Letter to the Editor: Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder CancerKamil Malshy, Matthew Steidle, William Tabayoyong, et al.
The Journal of Urology|November 21, 2002
Increased expression of the acid sphingomyelinase-like protein ASML3a in bladder tumorsKate O Wright, Edward M Messing, Jay E Reeder
The Journal of Biological Chemistry|July 31, 2002
Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPMDakun Wang, Zaibo Li, Edward M Messing, et al.
Oncogene|January 9, 2004
DBCCR1 mediates death in cultured bladder tumor cellsKate O Wright, Edward M Messing, Jay E Reeder
EMBO Reports|March 19, 2005
VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alphaZaibo Li, Dakun Wang, Edward M Messing, et al.
The Journal of Biological Chemistry|February 17, 2005
The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathwayDakun Wang, Zaibo Li, Edward M Messing, et al.
The Journal of Urology|August 3, 2010
Re: Dipstick pseudohematuria: unnecessary consultation and evaluation. P. K. Rao, T. Gao, M. Pohl and J. S. Jones J Urol 2010; 183: 560-565Edward M Messing, Dragan Golijanin, Joy Knopf, et al.
Pageof 20

Showing results (61-70 of 199) with videos related to

Sort By:
Pageof 20
Expert Review of Anticancer Therapy|July 23, 2025
Implementation challenges of single-instillation intravesical chemotherapy following transurethral resection of bladder tumorKamil Malshy, Alexis Steinmetz, Edward M Messing
Current Opinion in Urology|August 2, 2008
Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factorsKatia Noyes, Eric A Singer, Edward M Messing
The Canadian Journal of Urology|December 3, 2008
Androgen deprivation therapy for advanced prostate cancer: why does it fail and can its effects be prolonged?Eric A Singer, Dragan J Golijanin, Edward M Messing
Clinical Genitourinary Cancer|December 1, 2024
Letter to the Editor: Risk of Metachronous Upper Tract Urothelial Carcinoma After Ureteral Stenting in Patients With Bladder CancerKamil Malshy, Matthew Steidle, William Tabayoyong, et al.
The Journal of Urology|November 21, 2002
Increased expression of the acid sphingomyelinase-like protein ASML3a in bladder tumorsKate O Wright, Edward M Messing, Jay E Reeder
The Journal of Biological Chemistry|July 31, 2002
Activation of Ras/Erk pathway by a novel MET-interacting protein RanBPMDakun Wang, Zaibo Li, Edward M Messing, et al.
Oncogene|January 9, 2004
DBCCR1 mediates death in cultured bladder tumor cellsKate O Wright, Edward M Messing, Jay E Reeder
EMBO Reports|March 19, 2005
VHL protein-interacting deubiquitinating enzyme 2 deubiquitinates and stabilizes HIF-1alphaZaibo Li, Dakun Wang, Edward M Messing, et al.
The Journal of Biological Chemistry|February 17, 2005
The SPRY domain-containing SOCS box protein 1 (SSB-1) interacts with MET and enhances the hepatocyte growth factor-induced Erk-Elk-1-serum response element pathwayDakun Wang, Zaibo Li, Edward M Messing, et al.
The Journal of Urology|August 3, 2010
Re: Dipstick pseudohematuria: unnecessary consultation and evaluation. P. K. Rao, T. Gao, M. Pohl and J. S. Jones J Urol 2010; 183: 560-565Edward M Messing, Dragan Golijanin, Joy Knopf, et al.
Pageof 20